Abstract
Background: There have been increasing reported cases of new-onset or aggravation of pre-existing dermatoses after the implementation of COVID-19 vaccination.
Case Presentation: An elderly male was presented with multiple annular scaly plaques all over the body two weeks following administration of the first dose of Oxford-AstraZeneca COVID-19 vaccine. The lesions further aggravated after taking the second dose of the vaccine. The clinical and histopathology features were suggestive of annular plaque psoriasis.
Conclusion: We report this first case of de novo plaque psoriasis following the Oxford- AstraZeneca COVID-19 vaccine, and it signifies a potential side effect of autoimmune reactivation after COVID vaccination.
Keywords: Psoriasis, COVID-19 vaccine, annular, astrazeneca, hypertension, psoriasis.
Graphical Abstract
[http://dx.doi.org/10.1016/j.jaad.2021.03.092] [PMID: 33838206]
[http://dx.doi.org/10.1038/s41591-020-01194-5] [PMID: 33335323]
[http://dx.doi.org/10.1111/ced.14895] [PMID: 34398977]
[http://dx.doi.org/10.1111/jdv.17561] [PMID: 34309932]
[http://dx.doi.org/10.1111/jdv.17449] [PMID: 34131967]
[http://dx.doi.org/10.34172/hpp.2021.32] [PMID: 34195051]
[http://dx.doi.org/10.1016/j.jdcr.2021.08.035] [PMID: 34522741]
[http://dx.doi.org/10.1111/1346-8138.16137] [PMID: 34487570]
[http://dx.doi.org/10.1111/jdv.17582] [PMID: 34363647]
[http://dx.doi.org/10.1111/dth.15110] [PMID: 34427024]
[http://dx.doi.org/10.1111/dth.15055] [PMID: 34231301]
[http://dx.doi.org/10.1111/jdv.17502] [PMID: 34236728]